Abstract
Biochemical properties of nucleotide pyrophosphatase/phosphodiesterase (NPP) in rat serum have been described by assessing its nucleotide phosphodiesterase activity, using p-nitrophenyl-5′-thymidine monophosphate (p-Nph-5′-TMP) as a substrate. It was demonstrated that NPP activity shares some typical characteristics described for other soluble NPP, such as divalent cation dependence, strong alkaline pH optimum (pH 10.5), inhibition by glycosaminoglycans, and K m for p-Nph-5′-TMP hydrolysis of 61.8 ± 5.2 μM. In order to characterize the relation between phosphodiesterase and pyrophosphatase activities of NPP, we have analyzed the effects of different natural nucleotides and nucleotide analogs. ATP, ADP, and AMP competitively inhibited p-Nph-5′-TMP hydrolysis with K i values ranging 13–43 μM. Nucleotide analogs, α,β-metATP, BzATP, 2-MeSATP, and dialATP behaved as competitive inhibitors, whereas α,β-metADP induced mixed inhibition, with K i ranging from 2 to 20 μM. Chromatographic analysis revealed that α,β-metATP, BzATP, and 2-MeSATP were catalytically degraded in the serum, whereas dialATP and α,β-metADP resisted hydrolysis, implying that the former act as substrates and the latter as true competitive inhibitors of serum NPP activity. Since NPP activity is involved in generation, breakdown, and recycling of extracellular adenine nucleotides in the vascular compartment, the results suggest that both hydrolyzable and non-hydrolyzable nucleotide analogs could alter the amplitude and direction of ATP actions and could have potential therapeutic application.
Similar content being viewed by others
References
Kunapuli SP, Daniel JL (1998) P2 receptor subtypes in the cardiovascular system. Biochem J 336:513–523
Robson S, Sevigny J, Imai M, Guckelberger O, Enjyoji K (2000) Thromboregulatory potential of endothelial CD39/nucleoside triphosphate diphosphohydrolase: modulation of purinergic signalling in platelets. Emerg Ther Targets 4:155–171
Marcus A, Broekman M, Drosopoulos J, Pinsky D, Islam N, Gayle R III, Maliszewski C (2001) Thromboregulation by endothelial cells: significance for occlusive vascular disease. Arterioscler Thromb Vasc Biol 21:178–182
Birk AV, Broekman MJ, Gladek EM, Robertson HD, Drosopoulos JH, Marcus AJ, Szeto HH (2002) Role of extracellular ATP metabolism in regulation of platelet reactivity. J Lab Clin Med 140:166–175
Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, Baricordi OR (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587–600
Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413–492
Valera S, Hussy N, Evans RJ, Adami N, North RA, Suprenant A, Buell G (1994) A new class of ligand-gated channel defined by P2X receptor for extracellular ATP. Nature 371:516–5519
King BF, Townsend-Nicholson A, Burnstock G (1998) Metabotropic receptor for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors. Trends Pharmacol Sci 19:506–514
Hasko G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7:759–770
Zimmermann H (1999) Nucleotides and cd39: principal modulatory players in hemostasis and thrombosis. Nat Med 5:987–988
Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362:299–309
Yegutkin GG, Samburski SS, Jalkanen S (2003) Soluble purine-converting enzymes circulate in human blood and regulate extracellular ATP level via counteracting pyrophosphatase and phosphotransfer reactions. FASEB J 17:1328–1330
Oses JP, Cardoso CM, Germano RA, Kirst IB, Rucker B, Furstenau CR, Wink MR, Bonan CD, Battastini AMO, Sarkis JJF (2004) Soluble NTPDase: an additional system of nucleotide hydrolysis in rat blood serum. Life Sci 74:3275–3284
Stefan C, Jansen S, Bollen M (2006) Modulation of purinergic signaling by NPP-type ectophosphodiesterases. Purinergic Signal 2:361–370
Stefan C, Jansen S, Bollen M (2005) NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem Sci 30:542–550
Yegutkin GG (2008) Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 1783:673–694
Coade SB, Pearson JD (1989) Metabolism of adenine nucleotides in human blood. Circ Res 65:531–537
Bollen M, Gijsbers R, Ceulemans H, Stalmans W, Stefan C (2000) Nucleotide pyrophosphatase/phosphodiesterase on the move. Crit Rev Biochem Mol Biol 35:393–432
Vollmayer P, Chair T, Goding JW, Sano K, Servos J, Zimmermann H (2003) Hydrolysis of diadenosine polyphosphates by nucleotide pyrophosphatase/phosphodiesterases. Eur J Biochem 270:2971–2978
Gijsbers R, Ceulemans H, Stalmans W, Bollen M (2001) Structural and catalytic similarities between nucleotide pyrophosphatase/phosphodiesterase and alkaline phosphatase. J Biol Chem 276:1361–1368
Lavrnja I, Bjelobaba I, Stojiljkovic M, Pekovic S, Mostarica-Stojkovic M, Stosic-Grujicic S, Nedeljkovic N (2009) Time-course changes in ectonucleotidase activities during experimental autoimmune encephalomyelitis. Neurochem Int 55:193–198
Markwell MA, Haas SA, Lieber L, Tolbert NA (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206–210
Voelter W, Zech K, Arnold P, Ludwig G (1980) Determination of selected pyrimidines, purines and their metabolites in serum and urine by reversed-phase ion-pair chromatography. J Chromatogr 199:345–354
Sakura H, Nagashima S, Nakahima A, Maeda M (1998) Characterization of fetal serum 5′-nucleotide phosphodiesterase: a novel function as a platelet aggregation inhibitor in fetal circulation. Thromb Res 91:83–89
Hosoda N, Hoshino S, Kanda Y, Katada T (1999) Inhibition of phosphodiesterase/pyrophosphatase activity of PC-1 by its association with glycosaminoglycans. Eur J Biochem 265:763–770
Frittitta L, Camastra S, Baratta R, Costanzo BV, D’Adamo M, Graci S, Spampinato D, Maddux BA, Vigneri R, Ferrannini E, Trischitta V (1999) A soluble PC-1 circulates in human plasma: relationship with insulin resistance and associated abnormalities. J Clin Endocrinol Metab 84:3620–3625
Furstenau CR, Trentin DS, Gossenheimer AN, Ramos DB, Casali EA, Barreto-Chaves MLM, Sarkis JJF (2008) Ectonucleotidase activities are altered in serum and platelets of L-NAME-treated rats. Blood Cells Mol Dis 41:223–229
Bruno AN, Oses JP, Amaral O, Coitinho A, Bonan CD, Battastini AMO, Sarkis JJF (2003) Changes in nucleotide hydrolysis in rat blood serum induced by pentylenetetrazol-kindling. Mol Brain Res 114:140–145
Grobben B, Roymans AD, Stefan C, Bollen M, Esmans EL, Slegers H (1999) An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma. J Neurochem 72:826–834
Colman RW (1990) Aggregin: a platelet ADP receptor that mediates activation. FASEB J 4:1425–1435
Burnstock G (1990) Purinergic mechanisms. Ann N Y Acad Sci USA 603:1–17
Burnstock G, Fisher B, Hoyle CHV, Maillard M, Ziganshin AU, Brizzolara AL, Von Isakkovics A, Boyer JL, Kendall Harden T, Jacobson KA (1994) Structure-activity relationships for derivates of adenosine 5′-triphosphate as agonists of P2-purinoreceptors: heterogeneity within P2x and P2y subtypes. Drug Dev Res 31:206–219
Picher M, Sevigny J, D’Orléans-Juste P, Beaudoin AR (1996) Hydrolysis of P2-purinoreceptor agonists by a purified ectonucleotidase from the bovine aorta, the ATP-diphosphohydrolyase. Biochem Pharmacol 51:1453–1460
Gendaszewska-Darmach E, Maszewska M, Zaklos M, Koziolkiewicz M (2003) Degradation of extracellular nucleotides and their analogs in HeLa and HUVEC cell cultures. Acta Biochim Pol 50:973–984
Acknowledgment
This study was supported by Serbian Ministry of Science and technology project No. E143005.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Laketa, D., Bjelobaba, I., Savic, J. et al. Biochemical characterization of soluble nucleotide pyrophosphatase/phosphodiesterase activity in rat serum. Mol Cell Biochem 339, 99–106 (2010). https://doi.org/10.1007/s11010-009-0373-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-009-0373-1